Literature DB >> 33545038

Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression.

Lei S Qi, Matthew H Larson, Luke A Gilbert, Jennifer A Doudna, Jonathan S Weissman, Adam P Arkin, Wendell A Lim.   

Abstract

Year:  2021        PMID： 33545038     DOI： 10.1016/j.cell.2021.01.019

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  3 in total

Review 1.  Optophysiology: Illuminating cell physiology with optogenetics.

Authors:  Peng Tan; Lian He; Yun Huang; Yubin Zhou
Journal:  Physiol Rev       Date:  2022-01-24       Impact factor: 37.312

Review 2.  CRISPR/Cas-Based Modifications for Therapeutic Applications: A Review.

Authors:  Nagaraj Bharathkumar; Abraham Sunil; Prabhakar Meera; Sam Aksah; Muthu Kannan; Konda Mani Saravanan; Thirunavukarasou Anand
Journal:  Mol Biotechnol       Date:  2021-11-06       Impact factor: 2.860

Review 3.  CRISPR-Cas gene editing technology and its application prospect in medicinal plants.

Authors:  Miaoxian Guo; Hongyu Chen; Shuting Dong; Zheng Zhang; Hongmei Luo
Journal:  Chin Med       Date:  2022-03-04       Impact factor: 5.455
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.